Skip to content
  • Home Home Home, current page.
  • Moments Moments Moments, current page.

Saved searches

  • Remove
  • In this conversation
    Verified accountProtected Tweets @
Suggested users
  • Verified accountProtected Tweets @
  • Verified accountProtected Tweets @
  • Language: English
    • Bahasa Indonesia
    • Bahasa Melayu
    • Català
    • Čeština
    • Dansk
    • Deutsch
    • English UK
    • Español
    • Filipino
    • Français
    • Hrvatski
    • Italiano
    • Magyar
    • Nederlands
    • Norsk
    • Polski
    • Português
    • Română
    • Slovenčina
    • Suomi
    • Svenska
    • Tiếng Việt
    • Türkçe
    • Ελληνικά
    • Български език
    • Русский
    • Српски
    • Українська мова
    • עִבְרִית
    • العربية
    • فارسی
    • मराठी
    • हिन्दी
    • বাংলা
    • ગુજરાતી
    • தமிழ்
    • ಕನ್ನಡ
    • ภาษาไทย
    • 한국어
    • 日本語
    • 简体中文
    • 繁體中文
  • Have an account? Log in
    Have an account?
    · Forgot password?

    New to Twitter?
    Sign up
zeynep's profile
zeynep tufekci
zeynep tufekci
zeynep tufekci
Verified account
@zeynep

Tweets

zeynep tufekciVerified account

@zeynep

Complex systems, wicked problems. Society, technology, science and more. @UNC professor. @NYTimes columnist. My newsletter is @insight: http://www.theinsight.org 

floating in a most peculiar way
theinsight.org
Joined August 2009

Tweets

  • © 2022 Twitter
  • About
  • Help Center
  • Terms
  • Privacy policy
  • Cookies
  • Ads info
Dismiss
Previous
Next

Go to a person's profile

Saved searches

  • Remove
  • In this conversation
    Verified accountProtected Tweets @
Suggested users
  • Verified accountProtected Tweets @
  • Verified accountProtected Tweets @

Promote this Tweet

Block

  • Tweet with a location

    You can add location information to your Tweets, such as your city or precise location, from the web and via third-party applications. You always have the option to delete your Tweet location history. Learn more

    Your lists

    Create a new list


    Under 100 characters, optional

    Privacy

    Copy link to Tweet

    Embed this Tweet

    Embed this Video

    Add this Tweet to your website by copying the code below. Learn more

    Add this video to your website by copying the code below. Learn more

    Hmm, there was a problem reaching the server.

    By embedding Twitter content in your website or app, you are agreeing to the Twitter Developer Agreement and Developer Policy.

    Preview

    Why you're seeing this ad

    Log in to Twitter

    · Forgot password?
    Don't have an account? Sign up »

    Sign up for Twitter

    Not on Twitter? Sign up, tune into the things you care about, and get updates as they happen.

    Sign up
    Have an account? Log in »

    Two-way (sending and receiving) short codes:

    Country Code For customers of
    United States 40404 (any)
    Canada 21212 (any)
    United Kingdom 86444 Vodafone, Orange, 3, O2
    Brazil 40404 Nextel, TIM
    Haiti 40404 Digicel, Voila
    Ireland 51210 Vodafone, O2
    India 53000 Bharti Airtel, Videocon, Reliance
    Indonesia 89887 AXIS, 3, Telkomsel, Indosat, XL Axiata
    Italy 4880804 Wind
    3424486444 Vodafone
    » See SMS short codes for other countries

    Confirmation

     

    Welcome home!

    This timeline is where you’ll spend most of your time, getting instant updates about what matters to you.

    Tweets not working for you?

    Hover over the profile pic and click the Following button to unfollow any account.

    Say a lot with a little

    When you see a Tweet you love, tap the heart — it lets the person who wrote it know you shared the love.

    Spread the word

    The fastest way to share someone else’s Tweet with your followers is with a Retweet. Tap the icon to send it instantly.

    Join the conversation

    Add your thoughts about any Tweet with a Reply. Find a topic you’re passionate about, and jump right in.

    Learn the latest

    Get instant insight into what people are talking about now.

    Get more of what you love

    Follow more accounts to get instant updates about topics you care about.

    Find what's happening

    See the latest conversations about any topic instantly.

    Never miss a Moment

    Catch up instantly on the best stories happening as they unfold.

    1. zeynep tufekci‏Verified account @zeynep 10 Dec 2020

      The BioNTech/Pfizer data is out—NEJM & FDA report. I understand this wasn't in the design & the long-term protection from single dose is open question. But given this sharp drop after 14 days after one dose, can someone explain why single dose isn't very very high on the agenda?pic.twitter.com/sxqwACGulz

      78 replies 334 retweets 1,479 likes
      Show this thread
    2. zeynep tufekci‏Verified account @zeynep 10 Dec 2020

      Yes, ideally there would have been a single-dose study as well. But here we are, and with a shortage that will mean many more people will die and everything else will be delayed. Personally, looking at that data, I'd quickly take one dose to give someone else a chance at one.

      17 replies 31 retweets 382 likes
      Show this thread
    3. zeynep tufekci‏Verified account @zeynep 10 Dec 2020

      zeynep tufekci Retweeted

      Maybe. There are 1256 people who did not receive the second dose in the trial. Yes, small group but what happened to them? I get it, ideally, we have a single dose study. Not so ideally, we have this data and a severe shortage. Seems worth a discussion. https://twitter.com/Valentine721/status/1337048321026875394 …

      zeynep tufekci added,

      This Tweet is unavailable.
      7 replies 13 retweets 251 likes
      Show this thread
    4. zeynep tufekci‏Verified account @zeynep 10 Dec 2020

      Pfizer reports "52.4% efficacy" for single dose but that includes the first seven days, before things kick in, when most new infections happened. At 10-12 days, the chart (eyeballing, no underlying data yet) looks ~80-85% efficacy. Unpleasant trade-off but reality is unpleasant.

      21 replies 48 retweets 430 likes
      Show this thread
      zeynep tufekci‏Verified account @zeynep 10 Dec 2020

      I'm hoping for immunology/virology people to tell us the potential trade-offs here. We know one side: due to shortages, hundreds of millions of people will not get vaccinated anytime soon. What does the calculation on the other side look like?

      7:09 AM - 10 Dec 2020
      • 17 Retweets
      • 260 Likes
      • Hazar Yüksel KWags1981 Aryeh Brusowankin whats happening Dr. Orna Izakson Daniela Ha 🌈🇩🇪🇪🇺🇯🇵🇵🇷 Kaiserin Augusta Ketil Froyn Mona van der Smitte #stayathome 😷 💉 #staysafe
      16 replies 17 retweets 260 likes
        1. New conversation
        2. zeynep tufekci‏Verified account @zeynep 10 Dec 2020

          At a minimum minimum, there should be an immediate single-dose trial launched, like yesterday. We sadly have a raging epidemic and will get results quickly but I think not giving this real thought now—and an explanation to the public—would be a grave mistake, given the stakes.

          12 replies 32 retweets 343 likes
          Show this thread
        3. zeynep tufekci‏Verified account @zeynep 10 Dec 2020

          zeynep tufekci Retweeted Stefan Baral

          Yeah, but given the stakes, "we don't know for sure so we won't vaccinate hundreds of millions" is not an acceptable answer. Shortage is a terrible trade-off, too. Why didn't they/we immediately launch a single dose trial after prelim data? They knew.https://twitter.com/sdbaral/status/1337053741015502850 …

          zeynep tufekci added,

          Stefan BaralVerified account @sdbaral
          Replying to @zeynep
          Dose de-escalation/non-inferiority trials tend to be very difficult to get pharma to agree to. But indeed, it is an open question of the non-inferiority of 6 weeks after one dose vs 2 weeks after the 2nd dose. Imagine Pfizer/moderna fights back on behalf of their shareholders.
          14 replies 24 retweets 219 likes
          Show this thread
        4. zeynep tufekci‏Verified account @zeynep 10 Dec 2020

          Look, folks, like all things pandemic, this is a trade-off. The immunology people should weigh in and explain to us about one side of the trade-off. The other side is a societal/ethical decision because we're bouncing potentially less efficacious against *not at all vaccinated*.

          14 replies 22 retweets 272 likes
          Show this thread
        5. zeynep tufekci‏Verified account @zeynep 10 Dec 2020

          This is immediately consequential. US plans to HOLD BACK for many millions now vaccination to preserve for second dose later. @ScottGottliebMD—Pfizer board member—disagrees: "We should get as many shots in our arms as possible right now." https://www.usatoday.com/story/news/health/2020/12/07/covid-vaccine-pfizer-board-member-disagrees-us-distribution-plan/3860363001/ …pic.twitter.com/6CGpcLlsSb

          26 replies 145 retweets 548 likes
          Show this thread
        6. zeynep tufekci‏Verified account @zeynep 10 Dec 2020

          zeynep tufekci Retweeted Michael Mina

          Let me ask this. We know older people need the booster more (from published data). But why we wouldn't launch a single-dose effort (randomized/blinded within) for <65 which can answer the questions about durability while immunizing millions more?https://twitter.com/michaelmina_lab/status/1337078184597217281 …

          zeynep tufekci added,

          Michael MinaVerified account @michaelmina_lab
          Agree! One dose = 2x people vaccinated The math is plain & simple Approach is broken. We do not do what makes sense: w/ rapid tests or making single dose vacc a priority when they work (both obvious benefits). We fail to do what's smart We choose perfect over most effective. https://twitter.com/zeynep/status/1337047714341785605 …
          Show this thread
          9 replies 21 retweets 194 likes
          Show this thread
        7. zeynep tufekci‏Verified account @zeynep 10 Dec 2020

          I wrote up the case for launching immediate trials to test a single-dose regime. Calling for volunteers among < 65 health-care workers for single dose and later booster seems like the minimal prudent response to this chart. We could know fairly quickly.https://zeynep.substack.com/p/vaccines-and-decision-making-with …

          9 replies 49 retweets 162 likes
          Show this thread
        8. End of conversation
        1. New conversation
        2. Judd Legum‏Verified account @JuddLegum 10 Dec 2020
          Replying to @zeynep

          Also I wonder if it's possible to get one dose now, get the 80% efficacy and then get the "booster" when supply increases? Or does it only work if you get it at 30 days?

          2 replies 0 retweets 18 likes
        3. zeynep tufekci‏Verified account @zeynep 10 Dec 2020
          Replying to @JuddLegum

          Gonna wait for virology/immunology people to give us their guesses. All we know is that re-infections after natural infection are extremely super duper rare, and there is a lot of evidence now that natural immunity (at least protecting from disease) lasts at least a year.

          0 replies 0 retweets 11 likes
        4. End of conversation
        1. JB Holston‏ @jholston 10 Dec 2020
          Replying to @zeynep

          Astra Zeneca/Oxford data indicates safe/effective for under 55 year old -- so similar point to one you're making here -- why not quick FDA/EUA for its use for folks in that age range? Attack superspreading, etc. $3/dose. 310 mill doses for U.S. Meanwhile compile data on > 55.

          1 reply 0 retweets 1 like
          Thanks. Twitter will use this to make your timeline better. Undo
          Undo

      Loading seems to be taking a while.

      Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

        Promoted Tweet

        false

        • © 2022 Twitter
        • About
        • Help Center
        • Terms
        • Privacy policy
        • Cookies
        • Ads info